What is Nebius's price-to-sales ratio?
Both figures are correct. Published price-to-sales numbers for NBIS have ranged from about 40 times to about 67 times, and the spread comes almost entirely from which revenue window each source used. Here is the arithmetic for each.
The same company, four waysas of 2026-09-02
| Revenue used | Amount | Price to sales |
|---|---|---|
| Last twelve months What most finance sites publish | $1.36B | 43.1× |
| 2026 guidance, midpoint The company's own forecast | $3.2B | 18.3× |
| 2026 guidance, low end | $3.0B | 19.5× |
| 2026 guidance, high end | $3.4B | 17.2× |
Each figure = $58.6B market capitalization ÷ the revenue in that row. Market capitalization = $213.93 × 274M shares.
Common questions about the multiple
What is NBIS's price-to-sales ratio?
It depends on which year of sales you divide by. Nebius Group (NASDAQ: NBIS) trades at 43.1 times trailing twelve-month sales and 18.3 times forward sales as of 2026-09-02. Trailing revenue is $1.36 billion; the company guides to $3.0–3.4 billion for 2026. Both numbers are correct. They measure different things.
Why do different sites show different P/S figures for NBIS?
Because each source picks a different revenue window and rarely says which. Published figures for NBIS have ranged from about 40 times to about 67 times. A site using the last four reported quarters gets a different answer from one using the last full fiscal year, and both differ from one using forward guidance. When revenue grows several hundred percent in a year, that choice changes the answer by more than a factor of two. The figure is not wrong so much as unlabeled.
Which number should you use?
That is a judgment call this site does not make for you. Trailing is a fact about what already happened. Forward relies on the company's own forecast, which may not hold. During hypergrowth the trailing number describes a company that no longer exists, and the forward number describes one that does not exist yet. Both are shown on every page here for that reason.